Real-time monitoring of Pseudomonas aeruginosa biofilm formation on endotracheal tubes in vitro
Pseudomonas aeruginosa is an opportunistic bacterial pathogen responsible for both acute and chronic infections in humans. In particular, its ability to form biofilm, on biotic and abiotic surfaces, makes it particularly resistant to host's immune defenses and current antibiotic therapies as we...
Saved in:
| Published in | BMC microbiology Vol. 18; no. 1; pp. 84 - 10 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
14.08.2018
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Pseudomonas aeruginosa is an opportunistic bacterial pathogen responsible for both acute and chronic infections in humans. In particular, its ability to form biofilm, on biotic and abiotic surfaces, makes it particularly resistant to host's immune defenses and current antibiotic therapies as well. Innovative antimicrobial materials, like hydrogel, silver salts or nanoparticles have been used to cover new generation catheters with promising results. Nevertheless, biofilm remains a major health problem. For instance, biofilm produced onto endotracheal tubes (ETT) of ventilated patients plays a relevant role in the onset of ventilation-associated pneumonia. Most of our knowledge on Pseudomonas aeruginosa biofilm derives from in vitro studies carried out on abiotic surfaces, such as polystyrene microplates or plastic materials used for ETT manufacturing. However, these approaches often provide underestimated results since other parameters, in addition to bacterial features (i.e. shape and material composition of ETT) might strongly influence biofilm formation.
We used an already established biofilm development assay on medically-relevant foreign devices (CVC catheters) by a stably transformed bioluminescent (BLI)-Pseudomonas aeruginosa strain, in order to follow up biofilm formation on ETT by bioluminescence detection. Our results demonstrated that it is possible: i) to monitor BLI-Pseudomonas aeruginosa biofilm development on ETT pieces in real-time, ii) to evaluate the three-dimensional structure of biofilm directly on ETT, iii) to assess metabolic behavior and the production of microbial virulence traits of bacteria embedded on ETT-biofilm.
Overall, we were able to standardize a rapid and easy-to-perform in vitro model for real-time monitoring Pseudomonas aeruginosa biofilm formation directly onto ETT pieces, taking into account not only microbial factors, but also ETT shape and material. Our study provides a rapid method for future screening and validation of novel antimicrobial drugs as well as for the evaluation of novel biomaterials employed in the production of new classes of ETT. |
|---|---|
| AbstractList | Background Pseudomonas aeruginosa is an opportunistic bacterial pathogen responsible for both acute and chronic infections in humans. In particular, its ability to form biofilm, on biotic and abiotic surfaces, makes it particularly resistant to host's immune defenses and current antibiotic therapies as well. Innovative antimicrobial materials, like hydrogel, silver salts or nanoparticles have been used to cover new generation catheters with promising results. Nevertheless, biofilm remains a major health problem. For instance, biofilm produced onto endotracheal tubes (ETT) of ventilated patients plays a relevant role in the onset of ventilation-associated pneumonia. Most of our knowledge on Pseudomonas aeruginosa biofilm derives from in vitro studies carried out on abiotic surfaces, such as polystyrene microplates or plastic materials used for ETT manufacturing. However, these approaches often provide underestimated results since other parameters, in addition to bacterial features (i.e. shape and material composition of ETT) might strongly influence biofilm formation. Results We used an already established biofilm development assay on medically-relevant foreign devices (CVC catheters) by a stably transformed bioluminescent (BLI)-Pseudomonas aeruginosa strain, in order to follow up biofilm formation on ETT by bioluminescence detection. Our results demonstrated that it is possible: i) to monitor BLI-Pseudomonas aeruginosa biofilm development on ETT pieces in real-time, ii) to evaluate the three-dimensional structure of biofilm directly on ETT, iii) to assess metabolic behavior and the production of microbial virulence traits of bacteria embedded on ETT-biofilm. Conclusions Overall, we were able to standardize a rapid and easy-to-perform in vitro model for real-time monitoring Pseudomonas aeruginosa biofilm formation directly onto ETT pieces, taking into account not only microbial factors, but also ETT shape and material. Our study provides a rapid method for future screening and validation of novel antimicrobial drugs as well as for the evaluation of novel biomaterials employed in the production of new classes of ETT. Keywords: Pseudomonas aeruginosa, Biofilm, Real-time monitoring, Endotracheal tube, Bioluminescence Pseudomonas aeruginosa is an opportunistic bacterial pathogen responsible for both acute and chronic infections in humans. In particular, its ability to form biofilm, on biotic and abiotic surfaces, makes it particularly resistant to host's immune defenses and current antibiotic therapies as well. Innovative antimicrobial materials, like hydrogel, silver salts or nanoparticles have been used to cover new generation catheters with promising results. Nevertheless, biofilm remains a major health problem. For instance, biofilm produced onto endotracheal tubes (ETT) of ventilated patients plays a relevant role in the onset of ventilation-associated pneumonia. Most of our knowledge on Pseudomonas aeruginosa biofilm derives from in vitro studies carried out on abiotic surfaces, such as polystyrene microplates or plastic materials used for ETT manufacturing. However, these approaches often provide underestimated results since other parameters, in addition to bacterial features (i.e. shape and material composition of ETT) might strongly influence biofilm formation. We used an already established biofilm development assay on medically-relevant foreign devices (CVC catheters) by a stably transformed bioluminescent (BLI)-Pseudomonas aeruginosa strain, in order to follow up biofilm formation on ETT by bioluminescence detection. Our results demonstrated that it is possible: i) to monitor BLI-Pseudomonas aeruginosa biofilm development on ETT pieces in real-time, ii) to evaluate the three-dimensional structure of biofilm directly on ETT, iii) to assess metabolic behavior and the production of microbial virulence traits of bacteria embedded on ETT-biofilm. Overall, we were able to standardize a rapid and easy-to-perform in vitro model for real-time monitoring Pseudomonas aeruginosa biofilm formation directly onto ETT pieces, taking into account not only microbial factors, but also ETT shape and material. Our study provides a rapid method for future screening and validation of novel antimicrobial drugs as well as for the evaluation of novel biomaterials employed in the production of new classes of ETT. BackgroundPseudomonas aeruginosa is an opportunistic bacterial pathogen responsible for both acute and chronic infections in humans. In particular, its ability to form biofilm, on biotic and abiotic surfaces, makes it particularly resistant to host’s immune defenses and current antibiotic therapies as well. Innovative antimicrobial materials, like hydrogel, silver salts or nanoparticles have been used to cover new generation catheters with promising results. Nevertheless, biofilm remains a major health problem. For instance, biofilm produced onto endotracheal tubes (ETT) of ventilated patients plays a relevant role in the onset of ventilation-associated pneumonia. Most of our knowledge on Pseudomonas aeruginosa biofilm derives from in vitro studies carried out on abiotic surfaces, such as polystyrene microplates or plastic materials used for ETT manufacturing. However, these approaches often provide underestimated results since other parameters, in addition to bacterial features (i.e. shape and material composition of ETT) might strongly influence biofilm formation.ResultsWe used an already established biofilm development assay on medically-relevant foreign devices (CVC catheters) by a stably transformed bioluminescent (BLI)-Pseudomonas aeruginosa strain, in order to follow up biofilm formation on ETT by bioluminescence detection. Our results demonstrated that it is possible: i) to monitor BLI-Pseudomonas aeruginosa biofilm development on ETT pieces in real-time, ii) to evaluate the three-dimensional structure of biofilm directly on ETT, iii) to assess metabolic behavior and the production of microbial virulence traits of bacteria embedded on ETT-biofilm.ConclusionsOverall, we were able to standardize a rapid and easy-to-perform in vitro model for real-time monitoring Pseudomonas aeruginosa biofilm formation directly onto ETT pieces, taking into account not only microbial factors, but also ETT shape and material. Our study provides a rapid method for future screening and validation of novel antimicrobial drugs as well as for the evaluation of novel biomaterials employed in the production of new classes of ETT. Pseudomonas aeruginosa is an opportunistic bacterial pathogen responsible for both acute and chronic infections in humans. In particular, its ability to form biofilm, on biotic and abiotic surfaces, makes it particularly resistant to host's immune defenses and current antibiotic therapies as well. Innovative antimicrobial materials, like hydrogel, silver salts or nanoparticles have been used to cover new generation catheters with promising results. Nevertheless, biofilm remains a major health problem. For instance, biofilm produced onto endotracheal tubes (ETT) of ventilated patients plays a relevant role in the onset of ventilation-associated pneumonia. Most of our knowledge on Pseudomonas aeruginosa biofilm derives from in vitro studies carried out on abiotic surfaces, such as polystyrene microplates or plastic materials used for ETT manufacturing. However, these approaches often provide underestimated results since other parameters, in addition to bacterial features (i.e. shape and material composition of ETT) might strongly influence biofilm formation.BACKGROUNDPseudomonas aeruginosa is an opportunistic bacterial pathogen responsible for both acute and chronic infections in humans. In particular, its ability to form biofilm, on biotic and abiotic surfaces, makes it particularly resistant to host's immune defenses and current antibiotic therapies as well. Innovative antimicrobial materials, like hydrogel, silver salts or nanoparticles have been used to cover new generation catheters with promising results. Nevertheless, biofilm remains a major health problem. For instance, biofilm produced onto endotracheal tubes (ETT) of ventilated patients plays a relevant role in the onset of ventilation-associated pneumonia. Most of our knowledge on Pseudomonas aeruginosa biofilm derives from in vitro studies carried out on abiotic surfaces, such as polystyrene microplates or plastic materials used for ETT manufacturing. However, these approaches often provide underestimated results since other parameters, in addition to bacterial features (i.e. shape and material composition of ETT) might strongly influence biofilm formation.We used an already established biofilm development assay on medically-relevant foreign devices (CVC catheters) by a stably transformed bioluminescent (BLI)-Pseudomonas aeruginosa strain, in order to follow up biofilm formation on ETT by bioluminescence detection. Our results demonstrated that it is possible: i) to monitor BLI-Pseudomonas aeruginosa biofilm development on ETT pieces in real-time, ii) to evaluate the three-dimensional structure of biofilm directly on ETT, iii) to assess metabolic behavior and the production of microbial virulence traits of bacteria embedded on ETT-biofilm.RESULTSWe used an already established biofilm development assay on medically-relevant foreign devices (CVC catheters) by a stably transformed bioluminescent (BLI)-Pseudomonas aeruginosa strain, in order to follow up biofilm formation on ETT by bioluminescence detection. Our results demonstrated that it is possible: i) to monitor BLI-Pseudomonas aeruginosa biofilm development on ETT pieces in real-time, ii) to evaluate the three-dimensional structure of biofilm directly on ETT, iii) to assess metabolic behavior and the production of microbial virulence traits of bacteria embedded on ETT-biofilm.Overall, we were able to standardize a rapid and easy-to-perform in vitro model for real-time monitoring Pseudomonas aeruginosa biofilm formation directly onto ETT pieces, taking into account not only microbial factors, but also ETT shape and material. Our study provides a rapid method for future screening and validation of novel antimicrobial drugs as well as for the evaluation of novel biomaterials employed in the production of new classes of ETT.CONCLUSIONSOverall, we were able to standardize a rapid and easy-to-perform in vitro model for real-time monitoring Pseudomonas aeruginosa biofilm formation directly onto ETT pieces, taking into account not only microbial factors, but also ETT shape and material. Our study provides a rapid method for future screening and validation of novel antimicrobial drugs as well as for the evaluation of novel biomaterials employed in the production of new classes of ETT. Abstract Background Pseudomonas aeruginosa is an opportunistic bacterial pathogen responsible for both acute and chronic infections in humans. In particular, its ability to form biofilm, on biotic and abiotic surfaces, makes it particularly resistant to host’s immune defenses and current antibiotic therapies as well. Innovative antimicrobial materials, like hydrogel, silver salts or nanoparticles have been used to cover new generation catheters with promising results. Nevertheless, biofilm remains a major health problem. For instance, biofilm produced onto endotracheal tubes (ETT) of ventilated patients plays a relevant role in the onset of ventilation-associated pneumonia. Most of our knowledge on Pseudomonas aeruginosa biofilm derives from in vitro studies carried out on abiotic surfaces, such as polystyrene microplates or plastic materials used for ETT manufacturing. However, these approaches often provide underestimated results since other parameters, in addition to bacterial features (i.e. shape and material composition of ETT) might strongly influence biofilm formation. Results We used an already established biofilm development assay on medically-relevant foreign devices (CVC catheters) by a stably transformed bioluminescent (BLI)-Pseudomonas aeruginosa strain, in order to follow up biofilm formation on ETT by bioluminescence detection. Our results demonstrated that it is possible: i) to monitor BLI-Pseudomonas aeruginosa biofilm development on ETT pieces in real-time, ii) to evaluate the three-dimensional structure of biofilm directly on ETT, iii) to assess metabolic behavior and the production of microbial virulence traits of bacteria embedded on ETT-biofilm. Conclusions Overall, we were able to standardize a rapid and easy-to-perform in vitro model for real-time monitoring Pseudomonas aeruginosa biofilm formation directly onto ETT pieces, taking into account not only microbial factors, but also ETT shape and material. Our study provides a rapid method for future screening and validation of novel antimicrobial drugs as well as for the evaluation of novel biomaterials employed in the production of new classes of ETT. Pseudomonas aeruginosa is an opportunistic bacterial pathogen responsible for both acute and chronic infections in humans. In particular, its ability to form biofilm, on biotic and abiotic surfaces, makes it particularly resistant to host's immune defenses and current antibiotic therapies as well. Innovative antimicrobial materials, like hydrogel, silver salts or nanoparticles have been used to cover new generation catheters with promising results. Nevertheless, biofilm remains a major health problem. For instance, biofilm produced onto endotracheal tubes (ETT) of ventilated patients plays a relevant role in the onset of ventilation-associated pneumonia. Most of our knowledge on Pseudomonas aeruginosa biofilm derives from in vitro studies carried out on abiotic surfaces, such as polystyrene microplates or plastic materials used for ETT manufacturing. However, these approaches often provide underestimated results since other parameters, in addition to bacterial features (i.e. shape and material composition of ETT) might strongly influence biofilm formation. We used an already established biofilm development assay on medically-relevant foreign devices (CVC catheters) by a stably transformed bioluminescent (BLI)-Pseudomonas aeruginosa strain, in order to follow up biofilm formation on ETT by bioluminescence detection. Our results demonstrated that it is possible: i) to monitor BLI-Pseudomonas aeruginosa biofilm development on ETT pieces in real-time, ii) to evaluate the three-dimensional structure of biofilm directly on ETT, iii) to assess metabolic behavior and the production of microbial virulence traits of bacteria embedded on ETT-biofilm. Overall, we were able to standardize a rapid and easy-to-perform in vitro model for real-time monitoring Pseudomonas aeruginosa biofilm formation directly onto ETT pieces, taking into account not only microbial factors, but also ETT shape and material. Our study provides a rapid method for future screening and validation of novel antimicrobial drugs as well as for the evaluation of novel biomaterials employed in the production of new classes of ETT. |
| ArticleNumber | 84 |
| Audience | Academic |
| Author | Iseppi, Ramona Sala, Arianna Ardizzoni, Andrea Girardis, Massimo Ferretti, Gianmarco Pericolini, Eva Blasi, Elisabetta Peppoloni, Samuele Colombari, Bruna |
| Author_xml | – sequence: 1 givenname: Eva orcidid: 0000-0002-5299-8197 surname: Pericolini fullname: Pericolini, Eva – sequence: 2 givenname: Bruna surname: Colombari fullname: Colombari, Bruna – sequence: 3 givenname: Gianmarco surname: Ferretti fullname: Ferretti, Gianmarco – sequence: 4 givenname: Ramona surname: Iseppi fullname: Iseppi, Ramona – sequence: 5 givenname: Andrea surname: Ardizzoni fullname: Ardizzoni, Andrea – sequence: 6 givenname: Massimo surname: Girardis fullname: Girardis, Massimo – sequence: 7 givenname: Arianna surname: Sala fullname: Sala, Arianna – sequence: 8 givenname: Samuele surname: Peppoloni fullname: Peppoloni, Samuele – sequence: 9 givenname: Elisabetta surname: Blasi fullname: Blasi, Elisabetta |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30107778$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kktv1DAURiNURB_wA9igSGzKIsV2HD82SFXFY6RKoAJry3GuU48Su9hOBf8ez0wLnQqUREnsc0_sm--4OvDBQ1W9xOgMY8HeJkwEYw3CosGE0IY9qY4w5bghWKCDB8-H1XFKa4QwFy1_Vh22CCPOuTiq1BXoqcluhnoO3uUQnR_rYOsvCZYhlDGdag1xGZ0PSde9C9ZNc21DnHV2wdflBD-EHLW5Lq46Lz2k2vn61uUYnldPrZ4SvLi7n1TfP7z_dvGpufz8cXVxftmYTtLccEOM7QFRbXrTCtJTQnvZomEASaSm0gjMmUBI8qGz5c0KDaJcYAvbmvakWu28Q9BrdRPdrOMvFbRT24EQR6VjdmYCZTtaPsfbjllMDTW9FQOSg9DaGN5iVlzvdq6bpZ9hMODL5qY96f6Md9dqDLeKIUkEEUVweieI4ccCKavZJQPTpD2EJSmChOCUCdkW9PUjdB2W6EurCiURQ61E8i816rIB5-223RupOu86JiWncrPus39Q5RhgdqZEp_w52C94s1dQmAw_86iXlNTq69U---phU_504z5KBeA7wMSQUgSrjMvbiJRVuElhpDahVbvQqhJatQmt2qjxo8p7-f9rfgP5-O4f |
| CitedBy_id | crossref_primary_10_1080_19932820_2024_2344320 crossref_primary_10_1016_j_apsusc_2021_152350 crossref_primary_10_3389_fphar_2022_944965 crossref_primary_10_1111_lam_13803 crossref_primary_10_1021_acsabm_4c00832 crossref_primary_10_1016_j_ultsonch_2024_106832 crossref_primary_10_3390_ma17071604 crossref_primary_10_3389_fcimb_2022_869761 crossref_primary_10_3390_foods8110541 crossref_primary_10_3390_pharmaceutics13060772 crossref_primary_10_1111_vde_13294 crossref_primary_10_3390_ijms20081868 crossref_primary_10_3390_molecules26164866 crossref_primary_10_3390_nano10061175 crossref_primary_10_1002_jobm_202400329 crossref_primary_10_1128_Spectrum_01047_21 crossref_primary_10_1016_j_mimet_2022_106644 crossref_primary_10_1016_j_talanta_2023_124655 crossref_primary_10_1080_14756366_2022_2155816 crossref_primary_10_1002_advs_202101301 crossref_primary_10_1007_s12088_020_00903_5 crossref_primary_10_1016_j_intimp_2021_108471 crossref_primary_10_3389_fmicb_2020_00035 crossref_primary_10_3389_fmicb_2022_1032520 crossref_primary_10_54393_pbmj_v5i3_349 crossref_primary_10_3390_antibiotics10080907 crossref_primary_10_3390_life14091079 crossref_primary_10_3390_app9153191 crossref_primary_10_1080_03067319_2019_1685091 crossref_primary_10_3390_microorganisms10122500 crossref_primary_10_47373_rfcs_2021_v23_1780 crossref_primary_10_1016_j_foodres_2022_112202 crossref_primary_10_1556_030_2021_01487 crossref_primary_10_3390_antibiotics13080687 crossref_primary_10_3390_md19040225 crossref_primary_10_3390_microorganisms8020243 crossref_primary_10_1016_j_nanoso_2021_100715 crossref_primary_10_1117_1_JBO_30_2_025002 crossref_primary_10_3390_ma13133037 |
| Cites_doi | 10.1001/archotol.130.3.339 10.1007/s001340051014 10.1002/ppul.21206 10.1111/j.1462-2920.2010.02208.x 10.2174/156652312799789244 10.1186/cc11357 10.1038/srep23347 10.1126/science.295.5559.1487 10.1099/jmm.0.05324-0 10.1001/archoto.2011.1133 10.1371/journal.pone.0181278 10.1099/jmm.0.05132-0 10.1038/sj.clpt.6100247 10.1128/AAC.00418-06 10.1128/AAC.34.10.1875 10.1038/nprot.2006.24 10.1080/08927014.2011.597051 10.3791/52239 10.1002/lary.20249 10.1128/AEM.00637-11 10.1099/jmm.0.45617-0 10.1073/pnas.0504266102 10.1038/nrd4000 10.1155/2017/5163575 10.1097/00006199-197009000-00065 10.1111/cmi.12184 10.1111/j.1365-2958.2005.05008.x 10.1128/jb.173.20.6558-6567.1991 10.1183/09031936.99.13354699 10.1016/S0167-7012(00)00122-6 10.1007/s13213-011-0273-y 10.1097/MLG.0b013e3181671b02 10.1128/JCM.27.9.2014-2018.1989 10.1128/IAI.64.2.518-523.1996 10.1128/AAC.01178-13 10.1016/j.clp.2010.05.003 10.1038/nrmicro2415 10.1038/nrd1008 10.1038/s41598-017-03656-2 10.1016/S0966-842X(01)02012-1 10.1016/j.otohns.2004.01.006 10.1016/j.mib.2007.09.010 10.1371/journal.pone.0170433 10.1128/IAI.00223-09 10.1111/j.1365-2672.2007.03612.x |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2018 BioMed Central Ltd. Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License. The Author(s). 2018 |
| Copyright_xml | – notice: COPYRIGHT 2018 BioMed Central Ltd. – notice: Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s). 2018 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 3V. 7QL 7T7 7U9 7X7 7XB 88E 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7N M7P P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s12866-018-1224-6 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Industrial and Applied Microbiology Abstracts (Microbiology A) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni) Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1471-2180 |
| EndPage | 10 |
| ExternalDocumentID | oai_doaj_org_article_f547c27356f14c4cbf8d09d8aacc7316 PMC6092828 A556997496 30107778 10_1186_s12866_018_1224_6 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: ; |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 7X7 88E 8FE 8FH 8FI 8FJ A8Z AAFWJ AAJSJ AASML AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HCIFZ HMCUK HYE IAO IGS IHR INH INR ISR ITC KQ8 LK5 LK8 M1P M48 M7P M7R MM. M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB ~02 -A0 3V. ACRMQ ADINQ AGJBV C24 CGR CUY CVF ECM EIF NPM PMFND 7QL 7T7 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS 7X8 5PM PUEGO |
| ID | FETCH-LOGICAL-c594t-7c2cfbe04acbc382b424b930dde929a49c817680097d5f9c8f8ae88aeef2b43c3 |
| IEDL.DBID | M48 |
| ISSN | 1471-2180 |
| IngestDate | Wed Aug 27 01:28:45 EDT 2025 Thu Aug 21 18:01:08 EDT 2025 Thu Jul 10 22:35:52 EDT 2025 Fri Jul 25 11:03:29 EDT 2025 Tue Jun 17 21:35:24 EDT 2025 Tue Jun 10 20:25:55 EDT 2025 Fri Jun 27 05:07:56 EDT 2025 Wed Feb 19 02:35:37 EST 2025 Thu Apr 24 23:12:16 EDT 2025 Tue Jul 01 04:31:29 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Biofilm Pseudomonas aeruginosa Bioluminescence Endotracheal tube Real-time monitoring |
| Language | English |
| License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c594t-7c2cfbe04acbc382b424b930dde929a49c817680097d5f9c8f8ae88aeef2b43c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-5299-8197 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12866-018-1224-6 |
| PMID | 30107778 |
| PQID | 2090603909 |
| PQPubID | 42585 |
| PageCount | 10 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_f547c27356f14c4cbf8d09d8aacc7316 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6092828 proquest_miscellaneous_2088746893 proquest_journals_2090603909 gale_infotracmisc_A556997496 gale_infotracacademiconefile_A556997496 gale_incontextgauss_ISR_A556997496 pubmed_primary_30107778 crossref_citationtrail_10_1186_s12866_018_1224_6 crossref_primary_10_1186_s12866_018_1224_6 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2018-08-14 |
| PublicationDateYYYYMMDD | 2018-08-14 |
| PublicationDate_xml | – month: 08 year: 2018 text: 2018-08-14 day: 14 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | BMC microbiology |
| PublicationTitleAlternate | BMC Microbiol |
| PublicationYear | 2018 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | S Stepanovic (1224_CR29) 2000; 40 M Allesen-Holm (1224_CR17) 2006; 59 Z Hazan (1224_CR20) 2006; 50 E Larson (1224_CR1) 1970; 19 1224_CR30 ME Rodrigues (1224_CR43) 2017; 12 CGM Gahan (1224_CR45) 2012; 12 JL del Pozo (1224_CR23) 2007; 82 Y Pan (1224_CR26) 2017; 7 C Sabia (1224_CR36) 2008; 104 TJ Inglis (1224_CR2) 1989; 27 G Vande Velde (1224_CR46) 2014; 16 KB Zur (1224_CR4) 2004; 130 A Ghafoor (1224_CR15) 2011; 77 IW Sutherland (1224_CR16) 2001; 9 D Davies (1224_CR22) 2003; 2 K-H Choi (1224_CR27) 2006; 1 H-C Flemming (1224_CR13) 2010; 8 JR Lawrence (1224_CR40) 1991; 173 J Malaty (1224_CR41) 2008; 118 E Banin (1224_CR38) 2005; 102 M Al-Samri (1224_CR8) 2010; 45 B Enjalbert (1224_CR44) 2009; 77 T Strateva (1224_CR12) 2011; 61 RC Silva (1224_CR6) 2012; 138 H Mulcahy (1224_CR19) 2010; 12 OC Tablan (1224_CR25) 2004; 53 C Ryder (1224_CR14) 2007; 10 M Kopel (1224_CR21) 2011; 27 S Paulone (1224_CR31) 2017; 12 H Savli (1224_CR35) 2003; 52 C Feldman (1224_CR3) 1999; 13 DH Solomon (1224_CR5) 2009; 119 J Perkins (1224_CR7) 2004; 130 S Gil-Perotin (1224_CR10) 2012; 16 T Bjarnsholt (1224_CR39) 2013; 12 JS Garland (1224_CR24) 2010; 37 P Lanotte (1224_CR34) 2004; 53 1224_CR28 K Tarquinio (1224_CR9) 2014; 58 S Dutka-Malen (1224_CR32) 1990; 34 S De Marco (1224_CR42) 2017; 2017 JA Schaber (1224_CR33) 2004; 53 CG Adair (1224_CR11) 1999; 25 JM Meyer (1224_CR37) 1996; 64 CB Whitchurch (1224_CR18) 2002; 295 |
| References_xml | – volume: 130 start-page: 339 year: 2004 ident: 1224_CR7 publication-title: Arch Otolaryngol Head Neck Surg doi: 10.1001/archotol.130.3.339 – volume: 25 start-page: 1072 year: 1999 ident: 1224_CR11 publication-title: Intensive Care Med doi: 10.1007/s001340051014 – volume: 45 start-page: 487 year: 2010 ident: 1224_CR8 publication-title: Pediatr Pulmonol doi: 10.1002/ppul.21206 – volume: 12 start-page: 1621 year: 2010 ident: 1224_CR19 publication-title: Environ Microbiol doi: 10.1111/j.1462-2920.2010.02208.x – volume: 12 start-page: 12 year: 2012 ident: 1224_CR45 publication-title: Curr Gene Ther doi: 10.2174/156652312799789244 – volume: 16 start-page: R93 year: 2012 ident: 1224_CR10 publication-title: Crit Care Lond Engl doi: 10.1186/cc11357 – ident: 1224_CR30 doi: 10.1038/srep23347 – volume: 295 start-page: 1487 year: 2002 ident: 1224_CR18 publication-title: Science doi: 10.1126/science.295.5559.1487 – volume: 53 start-page: 73 issue: Pt 1 year: 2004 ident: 1224_CR34 publication-title: J Med Microbiol doi: 10.1099/jmm.0.05324-0 – volume: 138 start-page: 251 year: 2012 ident: 1224_CR6 publication-title: Arch Otolaryngol Head Neck Surg. doi: 10.1001/archoto.2011.1133 – volume: 12 start-page: e0181278 year: 2017 ident: 1224_CR31 publication-title: PLoS One doi: 10.1371/journal.pone.0181278 – volume: 52 start-page: 403 issue: Pt 5 year: 2003 ident: 1224_CR35 publication-title: J Med Microbiol doi: 10.1099/jmm.0.05132-0 – volume: 82 start-page: 204 year: 2007 ident: 1224_CR23 publication-title: Clin Pharmacol Ther doi: 10.1038/sj.clpt.6100247 – volume: 50 start-page: 4144 year: 2006 ident: 1224_CR20 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00418-06 – volume: 34 start-page: 1875 year: 1990 ident: 1224_CR32 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.34.10.1875 – volume: 1 start-page: 153 year: 2006 ident: 1224_CR27 publication-title: Nat Protoc doi: 10.1038/nprot.2006.24 – volume: 27 start-page: 701 year: 2011 ident: 1224_CR21 publication-title: Biofouling doi: 10.1080/08927014.2011.597051 – ident: 1224_CR28 doi: 10.3791/52239 – volume: 119 start-page: 1633 year: 2009 ident: 1224_CR5 publication-title: Laryngoscope doi: 10.1002/lary.20249 – volume: 77 start-page: 5238 year: 2011 ident: 1224_CR15 publication-title: Appl Environ Microbiol doi: 10.1128/AEM.00637-11 – volume: 53 start-page: 841 issue: Pt 9 year: 2004 ident: 1224_CR33 publication-title: J Med Microbiol doi: 10.1099/jmm.0.45617-0 – volume: 102 start-page: 11076 year: 2005 ident: 1224_CR38 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0504266102 – volume: 53 start-page: 1 year: 2004 ident: 1224_CR25 publication-title: MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep – volume: 12 start-page: 791 year: 2013 ident: 1224_CR39 publication-title: Nat Rev Drug Discov doi: 10.1038/nrd4000 – volume: 2017 start-page: 1 year: 2017 ident: 1224_CR42 publication-title: Evid Based Complement Alternat Med doi: 10.1155/2017/5163575 – volume: 19 start-page: 122 year: 1970 ident: 1224_CR1 publication-title: Nurs Res doi: 10.1097/00006199-197009000-00065 – volume: 16 start-page: 115 year: 2014 ident: 1224_CR46 publication-title: Cell Microbiol doi: 10.1111/cmi.12184 – volume: 59 start-page: 1114 year: 2006 ident: 1224_CR17 publication-title: Mol Microbiol doi: 10.1111/j.1365-2958.2005.05008.x – volume: 173 start-page: 6558 year: 1991 ident: 1224_CR40 publication-title: J Bacteriol doi: 10.1128/jb.173.20.6558-6567.1991 – volume: 13 start-page: 546 year: 1999 ident: 1224_CR3 publication-title: Eur Respir J doi: 10.1183/09031936.99.13354699 – volume: 40 start-page: 175 year: 2000 ident: 1224_CR29 publication-title: J Microbiol Methods doi: 10.1016/S0167-7012(00)00122-6 – volume: 61 start-page: 717 year: 2011 ident: 1224_CR12 publication-title: Ann Microbiol doi: 10.1007/s13213-011-0273-y – volume: 118 start-page: 867 year: 2008 ident: 1224_CR41 publication-title: Laryngoscope doi: 10.1097/MLG.0b013e3181671b02 – volume: 27 start-page: 2014 year: 1989 ident: 1224_CR2 publication-title: J Clin Microbiol doi: 10.1128/JCM.27.9.2014-2018.1989 – volume: 64 start-page: 518 year: 1996 ident: 1224_CR37 publication-title: Infect Immun doi: 10.1128/IAI.64.2.518-523.1996 – volume: 58 start-page: 1723 year: 2014 ident: 1224_CR9 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01178-13 – volume: 37 start-page: 629 year: 2010 ident: 1224_CR24 publication-title: Clin Perinatol doi: 10.1016/j.clp.2010.05.003 – volume: 8 start-page: 623 year: 2010 ident: 1224_CR13 publication-title: Nat Rev Microbiol doi: 10.1038/nrmicro2415 – volume: 2 start-page: 114 year: 2003 ident: 1224_CR22 publication-title: Nat Rev Drug Discov doi: 10.1038/nrd1008 – volume: 7 start-page: 3423 year: 2017 ident: 1224_CR26 publication-title: Sci Rep doi: 10.1038/s41598-017-03656-2 – volume: 9 start-page: 222 year: 2001 ident: 1224_CR16 publication-title: Trends Microbiol doi: 10.1016/S0966-842X(01)02012-1 – volume: 130 start-page: 407 year: 2004 ident: 1224_CR4 publication-title: Otolaryngol--Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg doi: 10.1016/j.otohns.2004.01.006 – volume: 10 start-page: 644 year: 2007 ident: 1224_CR14 publication-title: Curr Opin Microbiol doi: 10.1016/j.mib.2007.09.010 – volume: 12 start-page: e0170433 year: 2017 ident: 1224_CR43 publication-title: PLoS One doi: 10.1371/journal.pone.0170433 – volume: 77 start-page: 4847 year: 2009 ident: 1224_CR44 publication-title: Infect Immun doi: 10.1128/IAI.00223-09 – volume: 104 start-page: 970 year: 2008 ident: 1224_CR36 publication-title: J Appl Microbiol doi: 10.1111/j.1365-2672.2007.03612.x |
| SSID | ssj0017837 |
| Score | 2.3990836 |
| Snippet | Pseudomonas aeruginosa is an opportunistic bacterial pathogen responsible for both acute and chronic infections in humans. In particular, its ability to form... Background Pseudomonas aeruginosa is an opportunistic bacterial pathogen responsible for both acute and chronic infections in humans. In particular, its... BackgroundPseudomonas aeruginosa is an opportunistic bacterial pathogen responsible for both acute and chronic infections in humans. In particular, its ability... Abstract Background Pseudomonas aeruginosa is an opportunistic bacterial pathogen responsible for both acute and chronic infections in humans. In particular,... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 84 |
| SubjectTerms | Anti-Infective Agents Antibiotics Antiinfectives and antibacterials Antimicrobial agents Bacteria Biofilm Biofilms Biofilms - growth & development Bioluminescence Biomaterials Biomedical materials Catheters Catheters - microbiology Complications and side effects Cross infection Endotracheal tube Equipment Contamination Gram-positive bacteria Health aspects Hydrogels Immunosuppressive agents In Vitro Techniques - methods Infections Intratracheal intubation Intubation, Intratracheal - instrumentation Laboratory equipment Medical equipment Medical innovations Metabolism Methodology Microbial mats Microbiological research Microorganisms Monitoring Nanoparticles Opportunist infection Pathogens Physiological aspects Pneumonia Polystyrene Polystyrene resins Pseudomonas aeruginosa Pseudomonas aeruginosa - genetics Pseudomonas aeruginosa - growth & development Pseudomonas aeruginosa - metabolism Real time Real-time monitoring Salts Silver Studies Time Factors Tubes Ventilation Ventilators Virulence Virulence - genetics |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9RAEF-kIPgi1s_YWlYRBCE0H5v9eKzFUn0QqRb6tmw2uzVgN-WSFPzvnUn2wgVBX4TLw2Un5DIzOzO_y-5vCHnLmSuktSy1kC5SVhiR1kaUqTHK-aYqeGGmVb5f-Pkl-3xVXe20-sI1YTM98Ky4Y18xYSHHVtznzDJbe9lkqpHGWItdlzD6Qs7bgqn4_kAA7orvMHPJj3uIwhyRMyAmyFkpX2Whiaz_z5C8k5PW6yV3EtDZI_IwVo70ZP7F--SeC4_J_bmX5K8nRF9AyZdiq3h6M81T_MOOdp5-7d3YdHDO9NS4zXjdhq43tG6xWfcNXXYvUvi4ACB1gxzPcKdhrF1P20Dv2mHTPSWXZx-_n56nsXtCaivFhhS0Zn3tMmZsbUtZ1KxgtSoziGdQEhmmrMwBa-BGjqby8M1L4yQczoNsactnZC90wb0glJWeibLISwPW8N5J53JAtsp4r1xViIRkW21qG6nFscPFTz1BDMn1bAANBtBoAM0T8n655Hbm1fib8Ac00SKIlNjTCXAUHR1F_8tREvIGDayR9CLgqpprM_a9_vTtQp9UFVcArBQIvYtCflK3iZsUQA_Ik7WSPFxJwqy06-GtH-kYFXoNjprxrFSZSsjrZRivxJVuwXUjykDYZxzKyIQ8n91ueW4IxpkQQiZErBxypZj1SGh_TJzhPFMIrl_-D00ekAcFTiUkBmaHZG_YjO4VlGZDfTTNwt_XTTdV priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bi9UwEA66Ivgi3q2uEkUQhGKbprk8ySouqw8iqwvnLaRpciy47dqL4L93pienbhEWeh7aTDltJpmZL518Q8grwT1TzvHUgbtIObMyrawsUmu1D3XJBLNzlu8XcXLGP2_KTVxwG2Ja5d4mzoa67hyukQNI15nIAKHrdxe_UqwahV9XYwmN6-QGUpdhSpfcLIArl4C-4pfMXIm3A9higfgZcBN4rlSsfNFM2f-_Yb7kmdZZk5fc0PEdcjvGj_Rop_C75Jpv75Gbu4qSf-4TcwqBX4oF4-n5PFtx2Y52gX4d_FR3cM0O1Pp-2jZtN1haNViy-5wuexgpHL4FqNoj0zP80zhVfqBNS383Y989IGfHH79_OEljDYXUlZqPqXTMhcpn3LrKFYpVnPFKFxlYNQiMLNdO5YA4cDtHXQY4C8p6BT8fQLZwxUNy0Hatf0woLwKXBcsLG0oeglfe54BvtQ1B-5LJhGT73jQuEoxjnYufZgYaSpidAgwowKACjEjIm-WWix27xlXC71FFiyASY88Xun5r4jwz8GjwyrIoRci5464Kqs50rax1Dot0JeQlKtgg9UWLuTVbOw2D-fTt1ByVpdAArzQIvY5CYe5uG7cqQD8gW9ZK8nAlCXPTrZv348hE2zCYfyM5IS-WZrwT891a300oA8afCwgmE_JoN-yW9waTnEkpVULkakCuOmbd0jY_ZuZwkWmE2E-ufqyn5BbDSYLEv_yQHIz95J9B6DVWz-f59Rdf2i5O priority: 102 providerName: ProQuest |
| Title | Real-time monitoring of Pseudomonas aeruginosa biofilm formation on endotracheal tubes in vitro |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/30107778 https://www.proquest.com/docview/2090603909 https://www.proquest.com/docview/2088746893 https://pubmed.ncbi.nlm.nih.gov/PMC6092828 https://doaj.org/article/f547c27356f14c4cbf8d09d8aacc7316 |
| Volume | 18 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3ri9NAEF_ugeAX8W30LFEEQYimm80-Pohc5Y5T8DiqheKXZbPZrYW7RJNGvP_emW1aL3gIQlNodpIm855k9zeEvODMUWktSyyEi4RRI5LCiCwxRjlf5pRTE2b5nvKTGfs4z-c7ZNPeqmdge21ph_2kZs35618_Lt-Bwb8NBi_5mxZ8LMe6GOohiEgJ3yX7EJgE2ukn9uelgpABQnMM_jiByLZ5yXntKQZhKqD5_-2zrwSt4YTKKxHq-Da51aeW8eFaF-6QHVfdJTfWzSYv7xE9hZwwwV7y8UUwZHyiF9c-PmtdV9awz7SxcU23WFZ1a-Jiid28L-Lt8sYYPq6CKrZBEGj4p1VXuDZeVvHP5aqp75PZ8dGX9ydJ314hsbliq0RYan3hUmZsYTNJC0ZZobIUHB7kTIYpK8dQjOBKjzL38MtL4yRszgNtZrMHZK-qK_eIxCzzTGR0nBmfM--ddG4Mpa8y3iuXUxGRdMNNbXvscWyBca5DDSK5XgtAgwA0CkDziLzaHvJ9DbzxL-IJimhLiJjZYUfdLHRvghouDW5ZZDn3Y2aZLbwsU1VKY6zF_l0ReY4C1oiKUeG0m4Xp2lZ_-DzVh3nOFVReCohe9kQ-sNv0qxiADwikNaA8GFCC2drh8EaP9EbrNU1VytNMpSoiz7bDeCROhatc3SENxAXGIc-MyMO12m3vG7x1KoSQEREDhRwwZjhSLb8FUHGeKqy-H_8P25-QmxRNBhGC2QHZWzWdewo52qoYkV0xFyOyPzk6PZuOwpOOUbBG-J5Ovv4GDvY7Qw |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJwQviG8CAwwCISFFJI7jxA8IbbCpZaOayibtzTiOXSqxZDQNaP8UfyN3SRoWIe1tUvvQ-JImd76PX3y-I-SV4JalxnDfgLvwOdOJn-kk8rWW1uUxE0w3Wb5TMT7mn0_ikw3yZ70XBtMq1zaxMdR5afAdOYB0GYgAELr8cPbTx65RuLq6bqHRTot9e_4bIFv1fvIJ5Puasb3do49jv-sq4JtY8pWfGGZcZgOuTWailGWc8UxGAeg5hAqaS5OGEIPjBoc8dvDLpdqm8LUOaCMTwXWvkU0eAZQZkc2d3enhrF-3SADvdWunYSreVWD9BSJ2QGrgK30x8H5Nk4D_XcEFXzjM07zg-PZuk1tdxEq32yl2h2zY4i653vawPL9H1AxCTR9b1NPTxj7gi0JaOnpY2Tov4ZiuqLbLer4oykrTbIFNwk9pv2uSwscWAI6XWFsa_mlVZ7aii4L-WqyW5X1yfCX8fUBGRVnYR4TyyPEkYmGkXcyds6m1ISBqqZ2TNmaJR4I1N5XpSppjZ40fqoE2qVCtABQIQKEAlPDI2_6Us7aex2XEOyiinhBLcTcHyuVcdZqt4NbgkZMoFi7khpvMpXkg81RrY7AtmEdeooAVFtsoMJtnruuqUpOvM7Udx0ICoJNA9KYjcg27dbc5AviA9bkGlFsDSrAGZji8nkeqs0aV-qc7HnnRD-OZmGFX2LJGGnA3XED46pGH7bTrnxucQJAkSeqRZDAhB4wZjhSL702tchFIBPWPL7-t5-TG-OjLgTqYTPefkJsMFQbLDvMtMlota_sUAr9V9qzTNkq-XbWC_wV7R24B |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Real-time+monitoring+of+Pseudomonas+aeruginosa+biofilm+formation+on+endotracheal+tubes+in+vitro&rft.jtitle=BMC+microbiology&rft.au=Pericolini%2C+Eva&rft.au=Colombari%2C+Bruna&rft.au=Ferretti%2C+Gianmarco&rft.au=Iseppi%2C+Ramona&rft.date=2018-08-14&rft.issn=1471-2180&rft.eissn=1471-2180&rft.volume=18&rft.issue=1&rft_id=info:doi/10.1186%2Fs12866-018-1224-6&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12866_018_1224_6 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2180&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2180&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2180&client=summon |